About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

BrightPath Biotherapeutics Co., Ltd.(4594) Historical

4594
TSE Growth
BrightPath Biotherapeutics Co., Ltd.
44
JPY
0
(0.00%)
Dec 23, 3:30 pm JST
0.28
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
44.1
Dec 23, 7:36 pm JST
Summary Chart Historical News Financial Result
52 Week High Jan 11, 2024
99 JPY
52 Week Low Oct 28, 2024
41 JPY
Yearly High Jan 11, 2024
99 JPY
Yearly Low Oct 28, 2024
41 JPY

Latest Weekly Price

Date Opening High Low Closing Price Change % Volume
Dec 23, 2024 44 45 43 44 0 0.00% 1,353,700

Weekly Margin Balance

Date Closing Price % Avg. Price Volume Sell Positions(Shares) Buy Positions(Shares) Margin Ratio
Dec 20, 2024 44 -6.38% 47 6,536,700
Dec 13, 2024 47 -4.08% 48 3,754,200 1,496,000 9,761,200 6.52
Dec 6, 2024 49 -3.92% 51 5,567,500 1,496,000 9,620,900 6.43
Nov 29, 2024 51 -8.93% 54 5,546,800 1,496,000 9,204,000 6.15
Nov 22, 2024 56 +12.00% 52 6,272,000 1,499,200 9,357,200 6.24
Nov 15, 2024 50 +4.17% 48 2,024,400 1,496,000 9,546,700 6.38
Nov 8, 2024 48 -2.04% 48 4,863,100 1,496,000 9,638,100 6.44
Nov 1, 2024 49 +16.67% 47 4,882,000 1,496,000 9,552,800 6.39
Oct 25, 2024 42 -10.64% 45 6,606,000 1,506,900 10,202,000 6.77
Oct 18, 2024 47 0.00% 46 1,469,100 1,506,900 8,854,500 5.88
Oct 11, 2024 47 -4.08% 48 3,002,300 1,513,700 8,913,700 5.89
Oct 4, 2024 49 -7.55% 50 4,023,100 1,667,800 8,488,200 5.09
Sep 27, 2024 53 0.00% 51 1,443,700 1,667,800 7,227,500 4.33
Sep 20, 2024 53 +3.92% 50 2,869,600 1,691,300 7,261,200 4.29
Sep 13, 2024 51 -3.77% 50 3,342,600 1,691,300 7,175,200 4.24
Sep 6, 2024 53 -8.62% 54 5,593,900 1,691,300 7,265,300 4.30
Aug 30, 2024 58 0.00% 59 5,262,300 1,691,300 6,528,000 3.86
Aug 23, 2024 58 +1.75% 58 5,921,900 1,691,300 6,078,600 3.59
Aug 16, 2024 57 +7.55% 56 5,753,300 1,691,300 5,737,400 3.39
Aug 9, 2024 53 -17.19% 51 17,728,100 1,681,400 6,105,800 3.63